Skip to main content

Table 3 Baseline laboratory data among the studied groups

From: Evaluation of the frequency and patterns of thyroid dysfunction in patients with metabolic syndrome

 

MetS group (n= 100)

Control group (n= 100)

P value

Fasting blood glucose (mg/dl)

139.51 ± 14.32

83.16 ± 6.81

< 0.001

Cholesterol (mg/dl)

213.29 ± 49.82

165.66 ± 17.92

< 0.001

Triglyceride (mg/dl)

177.49 ± 39.44

122.64 ± 18.22

< 0.001

High-density lipoprotein (mg/dl)

45.20 ± 7.01

48.95 ± 4.95

0.03

Low-density lipoprotein (mg/dl)

150.41 ± 21.51

95.41 ± 16.45

< 0.001

VLDL (mg/dl)

29.31 ± 2.23

24.47 ± 3.63

0.03

TSH (μu/ml)

5.24 ± 1.80

3.24 ± 1.61

< 0.001

Free T3 (pg/ml)

3.36 ± 0.63

3.70 ± 1.01

0.39

Free T4 (ng/dl)

1.39 ± 0.33

1.12 ± 0.32

< 0.001

  1. Data was expressed in the form of mean (SD). P value was significant if < 0.05
  2. MetS, metabolic syndrome; VLDL, very low-density lipoprotein; TSH, thyroid-stimulating hormone; FT4, free thyroxine; FT3, free triiodothyronine